to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
Return to Top
Search Result Details
Back to Search Results
This page shows the details of why an item matched the keywords from your search.
One or more keywords matched the following items that are connected to
Angiotensin II receptor blockers in hypertension and renal disease.
Lack of evidence of blood pressure-independent protection by renin-angiotensin system blockade after renal ablation.
Antihypertensive efficacy of candesartan in comparison to losartan: the CLAIM study.
A comparative trial of controlled-onset, extended-release verapamil, enalapril, and losartan on blood pressure and heart rate changes.
Effects of blood pressure level on progression of diabetic nephropathy: results from the RENAAL study.
Cost-effectiveness of losartan in diabetic nephropathy: a Greek perspective.
The JNC 7 approach compared to conventional treatment in diabetic patients with hypertension: a double-blind trial of initial monotherapy vs. combination therapy.
Telmisartan is more effective than losartan in reducing proteinuria in patients with diabetic nephropathy.
Endothelin modulates angiotensin II-induced mitogenesis of human mesangial cells.
Reversal of diuretic-associated impaired glucose tolerance and new-onset diabetes: results of the STAR-LET study.
ACE inhibitor-mediated attenuation of mesangial cell growth. A role for endothelin.
Effects of nebivolol on aortic compliance in patients with diabetes and maximal renin angiotensin system blockade: the EFFORT study.
Long-term effects of patiromer for hyperkalaemia treatment in patients with mild heart failure and diabetic nephropathy on angiotensin-converting enzymes/angiotensin receptor blockers: results from AMETHYST-DN.